BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 19346856)

  • 1. Transient hepatic attenuation differences and focal liver lesions: sump effect due to primary arterial hyperperfusion.
    Colagrande S; Centi N; Pradella S; Duranti B; Belli G; Villari N
    J Comput Assist Tomogr; 2009; 33(2):259-65. PubMed ID: 19346856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Accuracy of liver lesion assessment using automated measurement and segmentation software in biphasic multislice CT (MSCT)].
    Puesken M; Juergens KU; Edenfeld A; Buerke B; Seifarth H; Beyer F; Suehling M; Osada N; Heindel W; Wessling J
    Rofo; 2009 Jan; 181(1):67-73. PubMed ID: 18975251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transient hepatic attenuation differences (THAD) not connected to focal lesions.
    Colagrande S; Carmignani L; Pagliari A; Capaccioli L; Villari N
    Radiol Med; 2002; 104(1-2):25-43. PubMed ID: 12386553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Meaning and etiopathogenesis of sectorial transient hepatic attenuation differences (THAD)].
    Colagrande S; Centi N; Carmignani L; Salvatore Politi L; Villari N
    Radiol Med; 2003 Mar; 105(3):180-7. PubMed ID: 12835641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidetector CT of the liver and hepatic neoplasms: effect of multiphasic imaging on tumor conspicuity and vascular enhancement.
    Francis IR; Cohan RH; McNulty NJ; Platt JF; Korobkin M; Gebremariam A; Ragupathi KI
    AJR Am J Roentgenol; 2003 May; 180(5):1217-24. PubMed ID: 12704026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of transient hepatic attenuation differences in biphasic helical CT.
    Chen WP; Chen JH; Hwang JI; Tsai JW; Chen JS; Hung SW; Su YG; Lee SK
    AJR Am J Roentgenol; 1999 Feb; 172(2):419-24. PubMed ID: 9930795
    [No Abstract]   [Full Text] [Related]  

  • 8. Transient hepatic attenuation difference (THAD) in patients without neoplasm: frequency, shape, distribution, and causes.
    Yamasaki M; Furukawa A; Murata K; Morita R
    Radiat Med; 1999; 17(2):91-6. PubMed ID: 10399775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Single-pass CT of hepatic tumors: value of globular enhancement in distinguishing hemangiomas from hypervascular metastases.
    Leslie DF; Johnson CD; MacCarty RL; Ward EM; Ilstrup DM; Harmsen WS
    AJR Am J Roentgenol; 1995 Dec; 165(6):1403-6. PubMed ID: 7484574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative evaluation of hepatocellular carcinoma: combined use of CT with arterial portography and hepatic arteriography.
    Kim HC; Kim TK; Sung KB; Yoon HK; Kim PN; Ha HK; Kim AY; Kim HJ; Lee MG
    AJR Am J Roentgenol; 2003 Jun; 180(6):1593-9. PubMed ID: 12760926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Spiral-CT of the liver: optimizing contrast medium administration and examination technique].
    Vogl TJ; Hidajat N; Schröder RJ; Pegios W; Langer R; Neuhaus P; Felix R
    Aktuelle Radiol; 1996 Jan; 6(1):7-12. PubMed ID: 8852767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation changes in periportal region during triple-phasic contrast-enhanced CT.
    Kanazawa S; Tanaka A; Yasui K; Akaki S; Hiraki Y
    Radiat Med; 1999; 17(2):97-103. PubMed ID: 10399776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular changes in hepatocellular carcinoma: correlation of radiologic and pathologic findings.
    Honda H; Tajima T; Kajiyama K; Kuroiwa T; Yoshimitsu K; Irie H; Aibe H; Shimada M; Masuda K
    AJR Am J Roentgenol; 1999 Nov; 173(5):1213-7. PubMed ID: 10541091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of focal liver lesions at biphasic spiral CT: randomized double-blind study of the effect of iodine concentration in contrast materials.
    Hänninen EL; Vogl TJ; Felfe R; Pegios W; Balzer J; Clauss W; Felix R
    Radiology; 2000 Aug; 216(2):403-9. PubMed ID: 10924561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic helical CT as a novel technique for diagnosing hepatic perfusion disorders.
    Chen JH; Chen WP; Huang CL; Shen WC
    Hepatogastroenterology; 1999; 46(25):303-7. PubMed ID: 10228812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nontumorous attenuation changes on CT arterial portography.
    Deflandre MF; Vilgrain V; Zins M; Najmark D; Arrivé L; Vullierme MP; Nahum H
    J Comput Assist Tomogr; 1994; 18(5):761-7. PubMed ID: 8089326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved diagnosis of hepatic perfusion disorders: value of hepatic arterial phase imaging during helical CT.
    Quiroga S; Sebastià C; Pallisa E; Castellà E; Pérez-Lafuente M; Alvarez-Castells A
    Radiographics; 2001; 21(1):65-81; questionnaire 288-94. PubMed ID: 11158645
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interpretation of transient hepatic attenuation differences in dynamic CT.
    Itai Y
    Radiographics; 2001; 21(4):875-6. PubMed ID: 11452060
    [No Abstract]   [Full Text] [Related]  

  • 19. Dual-phase helical CT of the liver: value of arterial phase scans in the detection of small (< or = 1.5 cm) malignant hepatic neoplasms.
    Hollett MD; Jeffrey RB; Nino-Murcia M; Jorgensen MJ; Harris DP
    AJR Am J Roentgenol; 1995 Apr; 164(4):879-84. PubMed ID: 7726040
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timing of parenchymal enhancement on dual-phase dynamic helical CT of the liver: how long does the hepatic arterial phase predominate?
    Frederick MG; McElaney BL; Singer A; Park KS; Paulson EK; McGee SG; Nelson RC
    AJR Am J Roentgenol; 1996 Jun; 166(6):1305-10. PubMed ID: 8633437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.